News

Coave Therapeutics, a genetic medicine company focused on developing innovative therapies, is pleased to announce its receipt of a grant from the ALS Association, part of a $2.9 million allocation to six organizations. These grants support the advancement

NeuroBo Pharmaceuticals, Inc. has obtained its first site Institutional Review Board approval from Dr. Alexander Prezioso, Investigator at Clinical Pharmacology of Miami in Hialeah, FL, to initiate the Phase 1 clinical trial

Form Bio and Ginkgo Bioworks have unveiled an innovative collaboration to revolutionize AAV gene therapy design and development. This partnership combines Ginkgo's expertise in cell programming and biosecurity

Incyte has disclosed that the U.S. Food and Drug Administration has accepted the Biologics License Application for axatilimab, an anti-CSF-1R antibody, for Priority Review. This application targets the treatment of chronic graft-versus-host disease

BeiGene, Ltd. declared today that the U.S. Food and Drug Administration has accepted its Biologics License Application for TEVIMBRA® combined with fluoropyrimidine- and platinum-containing

Genmab A/S and AbbVie have jointly announced that the U.S. Food and Drug Administration has given Priority Review status to their supplemental Biologics License Application

XYRA LLC, a private biopharmaceutical company focused on developing innovative therapies for cardiac rhythm disorders, is pleased to announce an agreement with the FDA regarding the next steps for its drug

Curi Bio, a leader in developing human stem cell-based platforms for drug discovery, has announced a Memorandum of Understanding for scientific collaboration with Genetox and DreamCIS

Alpha Cognition Inc, also known as Alpha Cognition, a biopharmaceutical company focused on developing novel treatments for severe neurodegenerative disorders, is excited to announce the submission of a new

MRM Health, a biopharmaceutical company in the clinical stage, has received approval from regulatory and ethics committees to commence an observational cross-sectional clinical trial. This trial aims to identify specific microbial and metabolic patterns